University of Iowa Health Care

Ophthalmology and Visual Sciences

EyeRounds.org

Posterior Ischemic Optic Neuropathy

William E. Flanary, MD; David Phillips, MD; Randy H. Kardon, MD, PhD

April 3, 2015

Initial Presentation

Chief Complaint

Decreased vision in both eyes following spinal surgery

History of Present Illness

The patient is a 64-year-old male admitted to the intensive care unit following a spinal surgery who reports profoundly decreased vision in both eyes upon waking the following morning.  His corrective lenses did not improve his vision. He was taken off all sedatives and extubated without issue early in the morning of his initial evaluation. The spinal surgery was 12 hours long with the patient in the prone position for the entirety of the case following intubation. Review of the clinical record revealed that the case was complicated by substantial blood loss requiring 6 units of packed red blood cells and hypotension that required 2 vasopressive agents (norepinephrine 0.07 mcg/kg/min over 7 hours for total of 602.5 mcg and phenylephrine 0.75 mcg/kg/min over 7 hours for a total of 128 mg) to maintain adequate mean arterial pressures during surgery. Post-operatively, the patient remained on phenylephrine 0.75 mcg/kg/min overnight to assist with blood pressure management while admitted to the ICU. Review of the operative report revealed several systolic and diastolic dips below 90 mmHg and 45 mmHg respectively and urine output from 8:00 am to 10:00 pm during the surgery was reported as 600 ml, below average for a surgery of this length.

Past Ocular History

  • None

Past Medical History

  • Severe back pain from degenerative disc disease
  • Neurogenic bladder
  • Benign prostate hypertrophy
  • Depression
  • Post-traumatic stress disorder
  • Barrett esophagus
  • Chronic obstructive pulmonary disease
  • Irritable bowel syndrome

Ocular Medications

  • None

Allergies

  • None

Family History

  • Non-contributory

Social History

  • Current 1.5 pack per day smoker with a 75 pack year history of smoking
  • Rare alcohol use

Ocular Examination

Visual Acuity without correction

  • OD:  Counts fingers at 1 foot
  • OS:  Counts fingers at 1 foot

Extraocular Motility: Full in both eyes

Pupils

  • OD: 2.5 mm dark, 1.5 mm light, sluggish reaction, no RAPD
  • OS: 2.5 mm dark, 1.5 mm light, sluggish reaction, no RAPD
  • Pupil contraction with near effort exceeded light reaction (light-near dissociation)

Intraocular Pressure

  • OD: 14 mmHg
  •   OS:  13 mmHg

Anterior Segment Examination

  • OD
    • Lids: Trace edema
    • Conjunctiva/Sclera: +2 serous chemosis, no injection
    • Cornea: Clear
    • AC: Deep and quiet
    • Iris: Normal
    • Lens: 1+ nuclear sclerosis
  • OS
    • Lids: Trace edema
    • Conjunctiva/Sclera: +2 serous chemosis, no injection
    • Cornea: Clear
    • AC: Deep and quiet
    • Iris: Normal
    • Lens: 1+ nuclear sclerosis

Dilated Fundus Examination

  • OD
    • Vitreous: Clear
    • Optic Nerve: Sharp border with no edema
    • Macula: Normal
    • Vessels: Normal
    • Periphery: Normal
  • OS
    • Vitreous: Clear
    • Optic Nerve: Sharp border with no edema
    • Macula: Normal
    • Vessels: Normal
    • Periphery: Normal

Clinical Course

It was recommended that further vasopressor medications be withheld unless absolutely necessary for life saving measures and that blood pressure be maintained using intravascular volume infusion.  To counteract hemodilution, we recommended that the hemoglobin be maintained above 8 mg/dl using blood transfusions, if needed. The head of the bed should not be elevated more than 10 degrees to facilitate optic nerve perfusion.  Brimonidine twice daily was started in both eyes with the theoretical benefit of increasing perfusion pressure to the globe by decreasing intraocular pressure. The patient was followed daily and discharged to a rehabilitation facility. On his two month follow-up exam his vision had improved to counts fingers at 10 feet in the right eye and counts fingers at 3 feet in the left eye, the exam was largely unchanged except for moderate optic nerve pallor OU.

DIAGNOSIS

Posterior ischemic optic neuropathy (PION)

Discussion

Posterior ischemic optic neuropathy (PION) is a potentially devastating condition characterized by acute, painless vision loss in one or both eyes.  PION can be classified into three types: arteritic PION caused by giant cell arteritis, non-arteritic PION, and perioperative PION.  Compared to anterior ischemic optic neuropathy (AION), little data has been published on PION, mostly in the form of case reports and anecdotal observations.   This is in large part due to the low incidence of this disease.  Over the past 20 years, more research has been done to better characterize this this condition.

Vascular Supply of the Posterior Optic Nerve

The optic nerve is divided into intraorbital, intracanalicular and intracranial segments. Posterior ischemic optic neuropathy is primarily due to ischemia of the intraorbital portion. Anterior ischemic optic neuropathy is primarily due to ischemia of the prelaminar and laminar portions where the optic nerve exits the globe (1). The main blood supply to this portion of the nerve is from the small branches of the posterior ciliary arteries. In posterior ischemic optic neuropathy, it is important to understand the blood supply to the intraorbital portion of the optic nerve posterior to the lamina cribrosa.  The following description of the blood supply to the optic nerve is taken from Ischemic Optic Neuropathies by Sohan Hayreh, Springer-Verlag Berlin Heidelberg 2011 (Figure 1)

Schematic representation of blood supply of the optic nerve

Figure 1: Schematic representation of blood supply of the optic nerve. A = arachnoid; C = choroid; CRA = central retinal artery; Col. Br. = Collateral branches supplying the optic nerve pial plexus; CRV = central retinal vein; D = dura; LC = lamina cribrosa; ON = optic nerve; PCA = posterior ciliary artery; PR = prelaminar region; R = retina; S = sclera; SAS = subarachnoid space (modified from Hayreh SS. Anatomy and physiology of the optic nerve head. Trans Am Acad Ophthalmol Otolaryngol. 1974;78:OP240–54 and also appearing in Ischemic Optic Neuropathies by Sohan Hayreh, Springer-Verlag Berlin Heidelberg 2011, used with permission from S.S. Hayreh).

The anterior segment is between the optic nerve head and the site of entry of the central retinal artery into the nerve. This part has two vascular systems for its supply:  1) a peripheral centripetal vascular system that is present in all cases, consisting of the pial vas­cular plexus, supplied by multiple pial branches originating from the peripapillary choroid, circle of Haller and Zinn, central retinal artery, ophthalmic artery and other orbital arteries and 2) an axial centrifugal vascular system that is pres­ent in 75% of optic nerves, supplied by 1–8 intraneural branches of the central retinal artery.

The posterior segment is between the site of entry of the central retinal artery into the nerve and extends backward to the orbital apex, before becoming the intracanalicular part. The posterior segment is primarily supplied by the peripheral cen­tripetal vascular system formed by the pial vascu­lar plexus, supplied by multiple small collateral arteries usually arising directly from the ophthal­mic artery and less often from other orbital arteries. In about 10% of the optic nerves there may be an axial centrifugal vascular system extending backward for a variable distance, formed by intraneural branches of the central reti­nal artery.

Since the intraorbital portion of the optic nerve (both anterior and posterior parts) are supplied by more than one artery system, there exists watershed vascular zones within the optic nerve, depending upon the vascular anatomy of a particular person. Watershed zones in the optic nerve make it particularly vulnerable to low perfusion pressure, in which the areas within a watershed zone suffer the most.

Structural abnormalities of the optic nerve (crowded nerve head with a small cup, also known as the 'disc at risk'), combined with vascular risk factors leave many patients predisposed to development of anterior ischemic optic neuropathy (AION) (Figure 2).  There are no known structural risk factors for PION (2).  These vascular anatomic relationships help to explain the differences in clinical presentation between PION and AION, thus resulting in distinct clinical entities.

absence of an optic cup and crowding of the vessels

Figure 2:  "Disc at risk."  Absence of an optic cup and crowding of the vessels.

Perioperative PION

Incidence

Multiple studies have evaluated the incidence of perioperative PION.  Most of the reported cases are associated with prolonged systemic surgical procedures, including spinal procedures and other orthopedic surgeries, coronary artery bypass, radical neck dissections, and many others (3-5).  The incidence is considered to be extremely low.  The largest study evaluating the incidence of PION following spinal surgery included 3,450 surgeries over a 9 year period.  Only 3 patients (0.087%) experienced vision loss consistent with PION (6).

Pathogenesis

PION is caused by reduction of blood flow and oxygenation to the intraorbital optic nerve.  This may occur due to a number or risk factors: a decrease in arterial perfusion pressure due to hypotension from volume blood loss, an increase in peripheral vascular resistance causing reduction in downstream blood flow, an increase in peripheral venous pressure from orbital edema, an increase in intraocular pressure, or a decrease in blood oxygen carrying capacity (7).  Reduced optic nerve perfusion can occur in multiple ways during surgery.  Increased orbital venous pressure is common in surgeries which incorporate prone positioning, particularly spinal surgery.  Cheng et al. found that prone positioning during anesthesia increases intraocular pressure, which likely reflects elevated orbital venous pressure (8).  A system in which orbital venous pressure is high will be more susceptible to decreases in arterial pressure, placing the optic nerve at risk.  Intraoperative use of vasopressors can also increase resistance to blood flow to the optic nerve.  Pressor medications help raise central arterial pressure at the expense of  downstream blood flow to small arterioles and capillary networks, including the pial capillary network supplying the posterior optic nerve.  Lastly, a decrease in blood oxygen carrying capacity caused by anemia and intraoperative hemodilution may further complicate the surgical course by increasing the risk of PION.  In one study, evaluating the effects of profound anemia on brain tissue in rabbits, results suggest hemoglobin less than 2.4 g/dl reduced cerebral metabolic rate to 50% of baseline (9).

Some studies suggest that patient specific factors may contribute to the development of PION.  Sadda et al., in a study evaluating 28 patients with perioperative PION, found that 71% of patients had one or more risk factors for atherosclerotic disease (2).  This result seems logical, in that one would expect the incidence of PION to be much higher if only perioperative events were contributing to the disease process.  Contrarily, there have been cases of PION in healthy subjects without systemic vascular risk factors (2).  The pathogenesis is likely multifactorial, involving multiple surgical and non-surgical insults to the optic nerve vasculature.

Clinical Features

Vision loss from perioperative PION is often bilateral and devastating when compared to arteritic or non-arteritic, non-surgical causes.  In a review of 83 cases of perioperative PION from 27 reports in the literature, 75% of patients reported vision loss in the acute post-operative period (<24 hours) with 76% having visual acuity of count fingers or worse and 54% of eyes having an initial acuity of no light perception (NLP) (7).  There was bilateral involvement in 60.9% of patients with no report of sequential involvement.  In a study by Sabba et al. of 36 eyes with perioperative PION, 44% had final visual acuity of HM or less (compared with 17% of eyes with PION from nonsurgical causes).  Patients with perioperative PION are also less likely to experience worsening of visual acuity during follow up, with only 6% of eyes progressing after the initial event (compared to 38% for nonarteritic PION) (2).  These studies paint a clinical picture of perioperative PION consisting of acute, often bilateral profound vision loss that is unlikely to worsen over time. 

Dilated fundus exam in the acute setting typically reveals normal appearing optic nerves without pallor or edema and a poor pupillary light reflex.  For perioperative PION, in which bilateral disease is common, a relative afferent pupil defect may not be detected unless the damage is asymmetric (10), but the poor pupil reaction to light in both eyes results in a light-near dissociation, with greater pupil contraction to an attempted near effort compared to the pupil response to bright light. It may be challenging to elicit accommodation to assess for light-near dissociation in patients with bilaterally poor acuity. In such situations, accommodation may be provoked by asking the patient to converge his eyes or to forcibly attempt to close the eyelids while the examiner holds them open. Development of optic disc pallor usually occurs within 6-8 weeks, but may occur much sooner if there is a massive infarct of the nerve (Figure 3).  There is a paucity of information regarding visual field patterns in patients with perioperative PION, owing in large part to the profound nature of the vision loss and less availability of kinetic perimetry for testing the peripheral visual field.  The pattern of visual field loss may depend on the vascular anatomy of the optic nerve in that particular person, the presence and location of vascular watershed zones, and the location along the intraorbital portion of the optic nerve where the ischemia occurs.

Optic disc pallor is usually seen 6-8 weeks after the initial ischemic event.

Figure 3:  Optic disc pallor is usually seen 6-8 weeks after the initial ischemic event.

Treatment

There is very little data regarding the treatment of perioperative PION.  There are case reports outlining multiple treatment options, including systemic corticosteroids, intraocular pressure reduction, and correction of hemodynamic instability (7).  There is currently not enough data collected in a controlled study to determine whether any of these interventions improve visual outcome.  Due to the rare incidence of perioperative PION, a controlled study comparing potential interventions would be extremely difficult to perform.  The best option for treating perioperative PION at this time is prevention in the form of shorter surgeries while minimizing head down, prone positioning.  Large volume blood loss is often unavoidable for many systemic surgeries; however, maintaining intravascular volume by administering intravenous fluids, replacement of blood to prevent hemodilution and reduced oxygen carrying capacity of the blood, and minimizing the use of vasopressor agents may help mitigate the risk factors that determine final visual outcome in PION.

Risk Factors for Perioperative PION

  • Severe and prolonged arterial hypotension
  • Increase in intraocular pressure
  • Prolonged systemic surgery
  • Large intraoperative blood loss (hemodilution and anemia)
  • Use of vasopressors causing reduced optic nerve blood flow
  • Prone position (raised intraorbital venous pressure)
  • Reverse Trendelenburg position
  • Systemic cardiovascular disease and autoregulatory dysfunction

Signs of Perioperative PION

  • Reduced pupil light reflex, light near dissociation of pupil
  • Central scotoma on confrontation visual field
  • Pale nerve usually develops 6-8 weeks after the insult, but may appear early if massive infarct

Symptoms of Perioperative PION

  • Profound vision loss <24 hours post-operatively (often count fingers or worse)
  • Bilateral in 60%

Management of Perioperative PION to improve optic nerve perfusion

  • Replacement of intravascular volume
  • Positioning the head at a small incline or at the level of the heart
  • Lowering of intraocular pressure
  • Minimize use of vasopressor agents

References

  1. Hayreh SS. Anterior ischaemic optic neuropathy I. Terminology and pathogenesis. Br J Ophthalmol 1974; 58:955–963.
  2. Sadda SR, Nee M, Miller NR, Biousse V, Newman NJ, Kouzis A. Clinical spectrum of posterior ischemic optic neuropathy. Am J  Ophthalmol 2001; 132:743–750.
  3. Katz DM, Trobe JD, Cornblath WT, Kline LB. Ischemic optic neuropathy after lumbar spine surgery. Arch Ophthalmol 1994; 112: 925–931.
  4. Marks SC, Jaques DA, Hirata RM, Saunders Jr JR. Blindness following bilateral radical neck dissection. Head Neck 1990; 12: 342–345.
  5. Rizzo JF, Lessell S. Posterior ischemic optic neuropathy during general surgery. Am J Ophthalmol 1987; 103:808–811.
  6. Stevens WR, Glazer PA, Kelley SD, et al. Ophthalmic complications after spinal surgery. Spine 22:1319–24, 1997
  7. Buono LM, Foroozan R. Perioperative posterior ischemic optic neuropathy: review of the literature. Surv Ophthalmol. 2005; 50:15–26.
  8. Cheng MA, Todorov A, Tempelhoff R, McHugh T, Crowder CM, Lauryssen C. The effect of prone positioning on intraocular pressure in anesthetized patients. Anesthesiology 2001; 95: 1351–1355.
  9. Morimoto Y, Mathru M, Martinez-Tica JF, Zornow MH. Effects of profound anemia on brain tissue oxygen tension, carbon dioxide tension, and pH in rabbits. J Neurosurg Anesthesiol 2001; 13:33–39.
  10. Hayreh SS. Posterior ischaemic optic neuropathy: clinical features, pathogenesis, and management. Eye 2004; 18:1188–1206.

Suggested citation format

Flanary WE, Phillips D, Kardon RH. Posterior Ischemic Optic Neuropathy. April 3, 2015; Available from: http://EyeRounds.org/cases/212-PION.htm

last updated: 04/03/2015
  Share this page: